Anokion develops novel peptide and protein therapeutic with very low immunogenicity. The company is focused on products for orphan diseases.
Anokion develops novel peptide and protein therapeutic with very low immunogenicity. The company is focused on products for orphan diseases.
Anokion develops novel peptide and protein therapeutic with very low immunogenicity. The company is focused on products for orphan diseases.